Page 32 - Seth Lederman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The biotech wants to help doctors measure T-cell immunity to the novel coronavirus.

Tonix Pharmaceuticals filed a patent application for TNX-1500, designed to prevent and treat autoimmune diseases like multiple sclerosis.

Home / Top News / Tonix Pharmaceuticals Announces Publication of Patent Application for TNX-1500 (Monoclonal Antibody Anti-CD40-Ligand) in Development for Preventing and Treating Organ Transplant Rejection and Treating Autoimmune Conditions Tonix Pharmaceuticals Announces Publication of Patent Application for TNX-1500 (Monoclonal Antibody Anti-CD40-Ligand) in Development for Preventing and Treating Organ Transplant Rejection and Treating Autoimmune Conditions GMP Production of TNX-1500 is Expected to be Available in the Third Quarter of 2021 CHATHAM, N.J., Jan. 14, 2021 (GLOBE NEWSWIRE) — T...

Further Research into Psilocybin Opens New Doors for Treatment FinancialBuzz.com News Commentary Share this article Share this article NEW YORK, Jan. 7, 2021 /PRNewswire/ -- Among the popular fields of study for biotech companies in recent years are gene editing, tissue engineering and regeneration, nanobiotechnology and others. In addition, new segments under the biotech umbrella are constantly being developed. For example, the medical cannabis segment has rapidly emerged in recent years, and the continuously growing acceptance of psychedelic drugs is further evidence. The perceptions about...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Tonix Pharmaceuticals and Massachusetts General Hospital (MGH) Enter into Research ... Tonix Pharmaceuticals Holding Corp.January 5, 2021 GMT Expands Ongoing Research Collaboration Between Tonix and MGH Studying TNX-1500 in Heart Transplantation TNX-1500 May Hold Potential in Treating Autoimmune Diseases Including Systemic Lupus Erythematosus, Rheumatoid Arthritis and Multiple Sclerosis CHATHAM, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the ...